Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I HOPE HE MAKES THE POOR BROTHERS LOOK LIKE SUSHI!
Choi hammering the Poor boys! A couple of clowns!
On June 14, 2013, the Company received a decision from the American Arbitration Association in the case filed by Ms. Walton on October 25, 2011, granting an Interim Award of Arbitrators to Ms. Walton in the amount of $1,080,938. This award includes $980,938 related to lost salary, bonuses and benefits and $100,000 related to the defamation claim, of which the defamation award was paid by the Company’s insurance policy. In addition the Company will be required to pay all reasonable legal fees and expenses incurred by Ms. Walton and expenses associated with any outplacement services. The Company has recorded an accrual of $1,630,000 and $1,450,000 associated with the claim and legal fees which is reflected as an accrued expense in the accompanying balance sheets as of May 31, 2013 and November 30, 2012, respectively.
MERCEDES WON ! WHAT A JOKE! 1.) an additional accrual relating to severance payment to a former executive of $219,000, and 2.) the write-off of approximately $379,000 related to the abandonment of certain previously incurred patent expenses."
MERCEDES WON ! WHAT A JOKE! 1.) an additional accrual relating to severance payment to a former executive of $219,000, and 2.) the write-off of approximately $379,000 related to the abandonment of certain previously incurred patent expenses."
Is that legal? Certainly not fair.
What a bunch of scumbags! Record date for New Shareholders is 6/7/13 and they send it out on June 27th! http://ih.advfn.com/p.php?pid=nmona&article=58199085
LOOKS LIKE THE POOR BROTHERS BOUGHT AGAIN TODAY!
KEEP BUYING IT'S THE ONLY WAY TO KEEP THIS PPS UP! http://ih.advfn.com/p.php?pid=nmona&article=56818409
MEXICO IS ALMOST GONE ! As of November 30, 2012 and November 30, 2011, the Company recorded a receivable of $1,115,505 and $1,656,476, respectively, in the accompanying consolidated balance sheets. As of November 30, 2012 and November 30, 2011, the Company recorded deferred revenue of $1,104,623 and $1,633,910, respectively, in the accompanying consolidated balance sheets. Accounts receivable is calculated using the present value of all of the monthly installments using a discount rate that reflects both the risk-free rate at the inception of the contract and the contract period. In accordance with the agreement, the Company received twelve installments of $50,000 during fiscal 2012 which is reflected in the consolidated statement of operations as of November 30, 2012 as licensee and interest income. The installment amounts that are to be received and recognized within the next twelve months have been classified as short-term as Accounts Receivable in the accompanying consolidated balance sheets.
Marketing Agreements
The Company has entered into definitive license agreements to market both the Company’s umbilical cord blood and menstrual stem cell programs in Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Pakistan, Peru and Venezuela. In October 2012, the Company sent notice of termination to the Company’s Venezuelan affiliate for failure to meet its payment obligation in accordance with the contract. Subsequent to the notice of termination, payment was received for outstanding processing and storage fees due from Venezuela. The Company is in the process of discussing a new agreement. In December 2012, the Company sent notice of termination to the Company’s affiliate in Ecuador for failure to meet its payment obligation in accordance with the contract. Subsequent to the notice of termination, payment was received for outstanding processing and storage fees due from Ecuador. The Company is in the process of discussing a new agreement.
Why are the POOR BROTHERS TRYING TO BUY CCEL TO KEEP THE PPS A FLOAT! ROTFLMFAO!
Poor Brothers Buying more shares !
Is this how you write 250,000 samples! THE POOR BROTHERS ARE GETTING DESPERATE !
KEEP BUYING POOR BROTHERS CCEL IS ONLY WORTH WHAT YOU BUY AND KEEP ON BUYING!http://ih.advfn.com/p.php?pid=nmona&article=54697745
I could have told anyone that CCEL will NEVER make it back to NASDAQ!
Great! We know that competitor will never make it to the Nasdaq!
Heck they will never even make it to the AMEX...
Oh...wait...wasn't that one of their reasons for doing the RS???
LOLOLOLOLOLOLOLOL!!!SO HILARIOUS!!! AS IF!!!LOLOLOLOLOLOLOLOL!
If The Poor Brothers keep buying Shares maybe CCEL can GO BACK to the NASDAQ! LMFAO!
CCEL 2.40 the crusher competitor after a 1 for 100 RS 0.0059 , who is LTAO ?
WAIT WAIT WAIT ! LMAO! NOBODY IS BUYING CCEL STOCK BUT THE POOR BROTHERS LMFAO!
CCEL 2.40 the competitor 0.0059 says it all , who's running out of money ?
HEY LOOK THE POOR BROTHERS DIDN'T BUY ANY SHARES TODAY!
Cryo-cell Internatio (CCEL)
2.4 ? 0.0 (0.00%)
Volume: 0 @- ET
NOW THIS IS FUNNY!
The Poor Brothers are OVER PAYING for their own Stock ! WHAT A JOKE!
Have you seen the competitor that was supposed to crush CCEL and steal CMEX at 0.0059 ,now I'd call that toilet paper .
Whatever... at least THEY are willing to buy stock...
Not like that creep SHYSTER SCHISSLER when he was CEO of the "competitor" (on what level???) cord blood conpany!
I still LMAO when I think about his $330 "purchase"! OMG!!!
Once Again Poor Brothers buying more toilet paper! http://ih.advfn.com/p.php?pid=nmona&article=54660884
Poor Brothers buying their own Chit!
Statement of Changes in Beneficial Ownership (4)
Date :
10/19/2012 @ 4:34PM
Source :
Edgar (US Regulatory)
Stock :
Cryo-cell International, Inc. (QB) (CCEL)
Quote :
2.28 -0.01 (-0.44%) @ 5:06PM
<SCRIPT language='JavaScript1.1' SRC="http://ad.doubleclick.net/adj/N3382.151895.INVESTORSHUB.ADVFN./B6040058.12;abr=!ie;sz=300x250;click=;ord=496149716?"> </SCRIPT> <NOSCRIPT> <A TARGET="_blank" HREF="http://ad.doubleclick.net/jump/N3382.151895.INVESTORSHUB.ADVFN./B6040058.12;abr=!ie4;abr=!ie5;sz=300x250;ord=496149716?"> <IMG SRC="http://ad.doubleclick.net/ad/N3382.151895.INVESTORSHUB.ADVFN./B6040058.12;abr=!ie4;abr=!ie5;sz=300x250;ord=496149716?" BORDER=0 WIDTH=300 HEIGHT=250 ALT="Advertisement"></A> </NOSCRIPT>
- Statement of Changes in Beneficial Ownership (4)
Print
Alert
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
1. Name and Address of Reporting Person *
PORTNOY DAVID
2. Issuer Name and Ticker or Trading Symbol
CRYO CELL INTERNATIONAL INC [ CCEL ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__ X __ Director _____ 10% Owner
__ X __ Officer (give title below) _____ Other (specify below)
Co-Chief Executive Officer
(Last) (First) (Middle)
700 BROOKER CREEK BLVD., SUITE 1800
3. Date of Earliest Transaction (MM/DD/YYYY)
10/17/2012
(Street)
OLDSMAR, FL 34677
(City) (State) (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date
2A. Deemed Execution Date, if any
3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code
V
Amount
(A) or (D)
Price
Common Stock
10/17/2012
P
6000
A
$2.30
141378
I
By Corporation (1)
Common Stock
20893
D
Common Stock
199080
I
By IRA
Common Stock
199738
I
By LLC (2)
Common Stock
51678
I
By Spouse
Common Stock
4854
I
As Cust for Son
Common Stock
4000
I
As Cust for Daughter
Common Stock
55219
I
By Corporation 2 (3)
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security
3. Trans. Date
3A. Deemed Execution Date, if any
4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code
V
(A)
(D)
Date Exercisable
Expiration Date
Title
Amount or Number of Shares
Stock Option
$1.72
12/1/2011
12/1/2021
Common Stock
200000
200000
D
Stock Option
$2.90
8/31/2011
8/31/2021
Common Stock
100000
300000
D
Explanation of Responses:
( 1)
Shares of Common Stock held by PartnerCommunity, as to which David I. Portnoy may be deemed the beneficial owner as Chairman of the Board and Secretary and as managing member of Mayim Management, LLC, which may exercise investment and voting discretion over such shares of Common Stock in accordance with the Investment Advisory Agreement.
( 2)
Shares of Common Stock held by Mayim Investments Limited Partnership, as to which David I.Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
( 3)
Shares of Common Stock held by uTIPu, Inc., as to which David I. Portnoy may be deemed the beneficial owner as Chairman of the Board and Secretary.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director
10% Owner
Officer
Other
PORTNOY DAVID
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677
X
Co-Chief Executive Officer
Signatures
/s/ David I. Portnoy
10/19/2012
** Signature of Reporting Person
Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*
If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:
File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
That's a bit disingenuous...
BYE BYE MEXICO ! On August 19, 2011, the Company received notification from Mexico that it was terminating the license agreement effective immediately due to an alleged breach of the license agreement. On October 17, 2011, the Company and Mexico entered into an amendment to the license agreement whereby the termination was revoked and Mexico began to pay the Company $1,863,000 in 37 monthly installments of $50,000 beginning on October 17, 2011 with a final payment of $13,000. Mexico will have no other continuing obligations to the Company for royalties or other license payments and the agreement will be effectively terminated once the entire $1,863,000 has been received. Mexico also has the option to pay off the amount early with no penalties. The amendment is expected to result in a reduction of licensee income in future periods once the $1,863,000 is paid in full.
As of August 31, 2012 and November 30, 2011, the Company recorded a receivable from Mexico of $1,252,947 and $1,656,476, respectively, and deferred revenue of $1,239,144 and $1,633,910, respectively, in the accompanying consolidated balance sheets. Accounts receivable is calculated using the present value of all of the monthly installments using a discount rate that reflects both the risk-free rate at the inception of the contract and the contract period. In accordance with the agreement, the Company received nine installments of $50,000 during the nine months ended August 31, 2012, which is reflected in the consolidated statement of operations as of August 31, 2012 as licensee and other income. The installment amounts that are to be received and recognized within the next twelve months have been classified as short-term as Accounts Receivable in the accompanying consolidated balance sheets.
"Soon" as in the CMEX deal two years ago . "Soon" like its competitor will be CFP and who is now looking to sell off its samples to pay bills ?
CCEL WILL RUN OUT OF MONEY SOON !POOR POOR BROTHERS
How much "time" does CCEL's competitor have 0.0065 ? Another RS ?
Matter of time and time isn't on CCEL's Side!
CCEL running out of money , seems I've heard that before . CCEL's competitor was buying CMEX , seems I heard that before , Mercedes , Mercedes , seems I've heard that before . How's CCEL's competitor doing , you know the one that you said was going to "crush" CCEL with all its affiliates and sample count . I believe the competitor is at , let me see, 0.0065 , let me check again , yup 0.0065 . Isn't that after a 1 for 100 RS ? Maybe the competitor should start up the frozen birthday cake campaign again , CCEL is at $2.30 . POOR POOR BROTHERS , really ?
POOR BROTHERS ARE GOING TO BE POOR SOON! At August 31, 2012, the Company had cash and cash equivalents of $2,707,608. The Company’s cash decreased by approximately $3,600,000 during the first nine months of fiscal 2012, primarily as a result of the payment of $3,200,000 for the cancellation of certain interests in certain Revenue Sharing Agreements and the stock repurchase plan pursuant to which the Company has repurchased 705,150 shares of the Company’s common stock for approximately $1,470,000. As of August 31, 2012, the Company had no long-term indebtedness.
MER-CED-ES !On October 25, 2011, Mercedes Walton, the Company’s former chief executive officer, filed a demand for arbitration with the American Arbitration Association. Ms. Walton is claiming breach of her employment agreement and defamation. Ms. Walton is seeking arbitration costs, attorneys’ fees, interest, compensatory, punitive and liquidated damages, as well as injunctive and declaratory relief in the amount of $5,000,000. On August 30, 2011, the Board of Directors of the Company terminated its Chief Executive Officer and former Chairman of the Board of Directors, Ms. Walton, for cause. In accordance with Ms. Walton’s employment agreement dated August 15, 2005, as amended July 16, 2007, Ms. Walton could be entitled to severance in the amount up to $950,000 related to lost salary, bonuses and benefits. In addition, the Company could be required to pay all reasonable legal fees and expenses incurred by Ms. Walton as a result of the termination, as well as outplacement services. The Company has recorded an accrual of approximately $950,000 as of August 31, 2012 and November 30, 2011, associated with the agreement. On August 24, 2011, the Board of Directors of the Company approved funding a Grantor trust to escrow the amounts that may become payable to Mercedes Walton under her respective Employment Agreement as a result of a Change in Control (as that term is defined in the respective employment agreements as a majority change in the Company’s Board of Directors). The Company believes that Ms. Walton was terminated for cause and therefore, the Company believes that Ms. Walton has not earned the right to this severance and intends to defend itself against the agreement. A hearing is scheduled for February 4, 2013.
BYE BYE MEXICO ! On August 19, 2011, the Company received notification from Mexico that it was terminating the license agreement effective immediately due to an alleged breach of the license agreement. On October 17, 2011, the Company and Mexico entered into an amendment to the license agreement whereby the termination was revoked and Mexico began to pay the Company $1,863,000 in 37 monthly installments of $50,000 beginning on October 17, 2011 with a final payment of $13,000. Mexico will have no other continuing obligations to the Company for royalties or other license payments and the agreement will be effectively terminated once the entire $1,863,000 has been received. Mexico also has the option to pay off the amount early with no penalties. The amendment is expected to result in a reduction of licensee income in future periods once the $1,863,000 is paid in full.
As of August 31, 2012 and November 30, 2011, the Company recorded a receivable from Mexico of $1,252,947 and $1,656,476, respectively, and deferred revenue of $1,239,144 and $1,633,910, respectively, in the accompanying consolidated balance sheets. Accounts receivable is calculated using the present value of all of the monthly installments using a discount rate that reflects both the risk-free rate at the inception of the contract and the contract period. In accordance with the agreement, the Company received nine installments of $50,000 during the nine months ended August 31, 2012, which is reflected in the consolidated statement of operations as of August 31, 2012 as licensee and other income. The installment amounts that are to be received and recognized within the next twelve months have been classified as short-term as Accounts Receivable in the accompanying consolidated balance sheets.
POOR BROTHERS BUYING MORE OF THEIR OWN CHIT! http://ih.advfn.com/p.php?pid=nmona&article=54455713
What did JOEY SELL SAMPLES write this for you POOR BROTHERS !
Only 600 this time POOR Brothers! http://ih.advfn.com/p.php?pid=nmona&article=54347544
Come on POOR BROTHERS Why are you trying so HARD to keep the PPS UP!
- Statement of Changes in Beneficial Ownership (4)
Date :
09/12/2012 @ 4:55PM
Source :
Edgar (US Regulatory)
Stock :
Cryo-cell International, Inc. (QB) (CCEL)
Quote :
2.17 -0.01 (-0.46%) @ 1:20PM
- Statement of Changes in Beneficial Ownership (4)
Print
Alert
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person *
PORTNOY DAVID
2. Issuer Name and Ticker or Trading Symbol
CRYO CELL INTERNATIONAL INC [ CCEL ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__ X __ Director _____ 10% Owner
__ X __ Officer (give title below) _____ Other (specify below)
Co-Chief Executive Officer
(Last) (First) (Middle)
700 BROOKER CREEK BLVD., SUITE 1800
3. Date of Earliest Transaction (MM/DD/YYYY)
9/10/2012
(Street)
OLDSMAR, FL 34677
(City) (State) (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date
2A. Deemed Execution Date, if any
3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code
V
Amount
(A) or (D)
Price
Common Stock
9/10/2012
P
1
A
$2.17
18101
D
Common Stock
9/10/2012
P
1000
A
$2.18
19101
D
Common Stock
9/11/2012
P
1250
A
$2.18
20351
D
Common Stock
9/12/2012
P
542
A
$2.18
20893
D
Common Stock
131778
I
By Corporation (1)
Common Stock
199080
I
By IRA
Common Stock
199738
I
By LLC (2)
Common Stock
51678
I
By Spouse
Common Stock
4854
I
As Cust for Son
Common Stock
4000
I
As Cust for Daughter
Common Stock
55219
I
By Corporation 2 (3)
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security
3. Trans. Date
3A. Deemed Execution Date, if any
4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code
V
(A)
(D)
Date Exercisable
Expiration Date
Title
Amount or Number of Shares
Stock Option
$1.72
12/1/2011
12/1/2021
Common Stock
200000
200000
D
Stock Option
$2.90
8/31/2011
8/31/2021
Common Stock
100000
300000
D
Explanation of Responses:
( 1)
Shares of Common Stock held by PartnerCommunity, as to which David I. Portnoy may be deemed the beneficial owner as Chairman of the Board and Secretary and as managing member of Mayim Management, LLC, which may exercise investment and voting discretion over such shares of Common Stock in accordance with the Investment Advisory Agreement.
( 2)
Shares of Common Stock held by Mayim Investments Limited Partnership, as to which David I.Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
( 3)
Shares of Common Stock held by uTIPu, Inc., as to which David I. Portnoy may be deemed the beneficial owner as Chairman of the Board and Secretary.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director
10% Owner
Officer
Other
PORTNOY DAVID
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677
X
Co-Chief Executive Officer
Signatures
/s/ David I. Portnoy
9/12/2012
** Signature of Reporting Person
Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*
If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:
File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Cryo-cell International, Inc. (QB) (USOTC:CCEL)
Historical Stock Chart
1 Year : From Sep 2011 to Sep 2012
Keep Buying your own CRAP POOR BROTHER! http://ih.advfn.com/p.php?pid=nmona&article=53928151
CHOI is SELLING ! http://ih.advfn.com/p.php?pid=nmona&article=53856169
- Statement of Changes in Beneficial Ownership (4)
Date :
08/15/2012 @ 12:32PM
Source :
Edgar (US Regulatory)
Stock :
Cryo-cell International, Inc." (QB) (CCEL)
Quote :
1.95 -0.16 (-7.58%) @ 5:00PM
<SCRIPT language='JavaScript1.1' SRC="http://ad.doubleclick.net/adj/N3941.132147.INVESTORSHUB/B6408975;abr=!ie;sz=300x600;pc=[TPAS_ID];ord=1348998521?"> </SCRIPT> <NOSCRIPT> <A TARGET="_blank" HREF="http://ad.doubleclick.net/jump/N3941.132147.INVESTORSHUB/B6408975;abr=!ie4;abr=!ie5;sz=300x600;pc=[TPAS_ID];ord=1348998521?"> <IMG SRC="http://ad.doubleclick.net/ad/N3941.132147.INVESTORSHUB/B6408975;abr=!ie4;abr=!ie5;sz=300x600;pc=[TPAS_ID];ord=1348998521?" BORDER=0 WIDTH=300 HEIGHT=600 ALT="Advertisement"></A> </NOSCRIPT>
- Statement of Changes in Beneficial Ownership (4)
Print
Alert
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person *
Gaines George
2. Issuer Name and Ticker or Trading Symbol
CRYO CELL INTERNATIONAL INC [ CCEL ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__ X __ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
700 BROOKER CREEK BLVD., SUITE 1800
3. Date of Earliest Transaction (MM/DD/YYYY)
8/13/2012
(Street)
OLDSMAR, FL 34677
(City) (State) (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date
2A. Deemed Execution Date, if any
3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code
V
Amount
(A) or (D)
Price
Common Stock
700000
I
By IRA
Common Stock
8/13/2012
P
3000
A
$2.11
3000
I
By IRA
Common Stock
8/13/2012
P
1500
A
$2.10
1500
I
By IRA
Common Stock
8/13/2012
P
1500
A
$1.99
1500
I
By IRA
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security
3. Trans. Date
3A. Deemed Execution Date, if any
4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code
V
(A)
(D)
Date Exercisable
Expiration Date
Title
Amount or Number of Shares
Stock Options
$2.80
8/30/2011
8/30/2012
Common Stock
20000 (1)
20000.
D
Explanation of Responses:
( 1)
Stock options vest at a rate of 1/3 per year commencing on August 30, 2011.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director
10% Owner
Officer
Other
Gaines George
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677
X
Signatures
George Gaines
8/15/2012
** Signature of Reporting Person
Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*
If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:
File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
OOPS ! POOR BROTHERS LOSING THEIR HANDLE ON CCEL! $1.80 Choi must be unloading this crap.
So has CCEL Notified Shareholders that it went Pink !
Yes you're right shame on them for having a pps of $2.04 while its competitor the 4th largest storage company is at 0.013 after a 1 for 100 RS and now needs almost a billion shares to fill up the juice bottle . Pink seems to be in even football players wear it .
CHEERS
Followers
|
28
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
5497
|
Created
|
05/26/05
|
Type
|
Free
|
Moderators |
Cryo-Cell International, Inc.(CCEL)
Company Information:
700 Brooker Creek Blvd.
Suite 1800
Oldsmar, FL 34677
Phone: 813-749-2100
Toll Free: 800-786-7235
Fax: 813-855-4745
Cryo-Cell International, Inc. was established in 1989 with a primary focus on the cryopreservation of umbilical cord (U-Cord®) stem cells for family use. Since our inception, we have been committed to the development and adoption of industry best practices and technologies.
Cord blood stem cell transplants have already changed-and saved-thousands of lives around the world. What's more, science is honing in on other miraculous uses for these precious cells, potentially impacting countless numbers of lives in the future.
Ever-committed to the highest quality, we treat every specimen of umbilical cord blood as if it were our own. Every sample we receive, process and preserve represents a potentially life-saving treatment for a child. This concept fuels our resolve to only hire the most talented candidates, develop and implement the most effective training and continuously fine-tune our processes. From the design and specifications of our collection kit, to the choice of each supplier, our dedication to quality remains unwavering.
Cryo-Cell International, Inc. ("the Company" or "Cryo-Cell") operates in one reportable segment and is principally engaged in cellular processing and cryogenic storage, with a current focus on the collection and preservation of umbilical cord (U-Cord®) blood stem cells for family use. The Company, in combination with its global affiliates currently stores over 200,000 cord blood specimens worldwide for the exclusive benefit of newborn babies and possibly other members of their families. The Company is one of the world's largest and most established private family cord blood stem cell banks in terms of the number of specimens preserved. Its headquarters facility in Oldsmar, Florida handles all aspects of its U.S.-based business operations, including the processing and storage of specimens. The specimens are stored in commercially available cryogenic storage units at the Company's technologically and operationally advanced facility in Oldsmar, Florida.
In recent years, the Company has expanded its research and development ("R&D") activities to develop technologies related to stem cells other than umbilical cord blood stem cells such as fetal and maternal stem cells harvested from the placenta. During 2006, the Company discovered novel technology related to menstrual stem cells. In November 2007, the Company announced the launch of its C'elleSM service related to this patent-pending technology, and the Company continues to focus its current research and development activities principally on the C'elle service and related new menstrual stem cell technologies. The Company is actively marketing the C'elle service which is available both through a bundled offer with the Company's U-Cord service and on a stand-alone basis.
Employees: At November 30, 2009, there are 48 full-time employees and 1 part-time employee on the staff of the Company. Additional employees and staff will be hired on an "as needed" basis. The Company believes its relationship with its employees is good. None of our employees are members of any labor union, and we are not a party to any collective bargaining agreement.
Here's a video which shows the importance of saving cord blood: http://video.foxnews.com/11461523/cord-blood-miracle/?category_id=949437d0db05ed5f5b9954dc049d70b0c12f2749
Cryo-Cell International, Inc. holds an equity position in Saneron CCEL Therapeutics (Saneron), a University of South Florida spin-out biotechnology company. Saneron is committed to advancing research using readily available, non-controversial cord blood stem cells. Saneron's research focus is to actively seek new cellular therapy discoveries for treatment of and intervention in devastating, life-threatening illness and conditions such as heart attack, Alzheimer's disease, stroke, and spinal cord injury.
For more information, visit Saneron's Web site: www.saneron-ccel.com
Cryo-Cell is International
In order to provide the Cryo-Cell U-Cord® Stem Cell Preservation Service abroad, we are establishing affiliates in countries around the world. Currently, we have affiliates in the following areas:
See page 15 of SEC filing for further details: http://www.sec.gov/Archives/edgar/data/862692/000119312511189394/d10q.htm
C'elle distributor opportunity for doctors that specialize in female issues. See video:
http://www.celle.com/distributorVideo.aspx#
_______________________________________________________________________________________________________________________________________________________
Cryo-Cell International, Inc. has been a publicly traded company since 1991. Governed by the Securities & Exchange Commission, our common stock trades under the OTC Bulletin Board symbol CCEL. We specialize in U-Cord® stem cell preservation for family use.
Investor Relations: http://www.cryo-cell.com/investor_relations/
Investor Information: To request Cryo-Cell's Investor's Information Kit, or to receive Cryo-Cell's press releases via email, please fill out this form: http://www.cryo-cell.com/investor_relations/investor_info.asp
Section 16 Filings: All Insiders Annual Reports Quarterly & Other Reports Stock Quote Fundamentals News Chart Real-Time Filings
_______________________________________________________________________________________________________________________________________________________
Recent News:
http://www.cryo-cell.com/investor_relations/
http://finance.yahoo.com/q/h?s=CCEL.OB+Headlines
http://www.nasdaq.com/aspxcontent/newsheadlines.aspx?symbol=CCEL&selected=CCEL&SourceCode=PMZ
Filings:
Transfer Agent:
Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York 10004
__________________________________________________________________________________________________________________________
Share Structure:
See SEC filing link for latest share structure info.
______________________________________
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn't a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |